Walleye Capital’s The Oncology Institute TOI Stock Holding History

Walleye Capital’s Portfolio TOI Stock Details TOI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	+445,832	New	+$1.87M	0.01%	1355

Other funds holding TOI

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

T3 Companies New York $93.7M AUM

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BCP

Blackhawk Capital Partners Thiensville, Wisconsin $306M AUM 25.68% 1-Year Est. Return

Fermata Advisors Sonoma, California $495M AUM 20.19% 1-Year Est. Return

MWA

Miller Wealth Advisors Ridgeway, Colorado $237M AUM 40.97% 1-Year Est. Return

Walleye Capital's TOI Position: Q2 2026 in Review

Walleye Capital opened a new position in The Oncology Institute (TOI) in Q2 2026: 445,832 shares worth $2.42M. The stake represents 0.01% of the portfolio and ranks #1355 among its holdings.

19 funds tracked by Wall St. Rank hold TOI as of Q2 2026.

Walleye Capital held 445,832 shares of The Oncology Institute worth $2.42M as of Q2 2026.
The Oncology Institute was a new Walleye Capital position in Q2 2026.
The Oncology Institute made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1355 holding.
19 funds tracked by Wall St. Rank held The Oncology Institute as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.